ADVERTISEMENT
Emerald Investments Exits Eris Lifesciences Via Bulk Deal For Rs 1,187.4 Crore
Shares of Eris Lifesciences closed 2.13% higher at Rs 1,238.85 apiece on the NSE.
22 Aug 2024, 10:22 PM IST 
Save
.png?auto=format%2Ccompress&fmt=avif&mode=crop&ar=16%3A9&q=60)
Eris Lifesciences Ltd.'s manufacturing facility. (Source: Company's official Facebook page)
Show Quick Read
Summary is AI Generated. Newsroom Reviewed
Emerald Investments Ltd., a public shareholder of Eris Lifesciences Ltd., exited the company's shareholding by offloading a stake worth Rs 1,187.4 crore in a bulk deal through an open market transaction on Thursday.
Emerald Investments sold 98.86 lakh shares at Rs 1,201 apiece. The public shareholder held a 7.27% stake in the company as of June 2024, according to the BSE data.
The stake was bought by Infinity Partners, a firm based in Poland. Infinity Partners mopped up the shares, representing a 7.27% stake, at Rs 1,201 apiece, totalling Rs 1,187.4 crore.
Shares of Eris Lifesciences closed 2.13% higher at Rs 1,238.85 apiece on the NSE, compared to a 0.17% advance in the benchmark Nifty.
Opinion
Eris Lifesciences Q4 Results: Profit Up 30%, But Misses Estimates
